Use of a Point-of-Care Progesterone Assay to Predict Onset of Parturition in the Bitch

被引:4
|
作者
Nothling, Johan O. [1 ]
Joone, Carolynne J. [2 ]
Hegarty, Evan [3 ]
Schooley, Elizabeth K. [3 ]
De Cramer, Kurt G. M. [1 ]
机构
[1] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Pretoria, South Africa
[2] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia
[3] IDEXX Labs Inc, Westbrook, ME USA
基金
新加坡国家研究基金会;
关键词
dog; whelp; chemiluminescent immunoassay; vaginoscopy; Catalyst; P4; in-house analyzer; IDEXX; PLASMA PROGESTERONE; SERUM PROGESTERONE; CANINE; BLOOD; TIME; TEMPERATURE; MATURATION; PREGNANCY; PRECISION; CORTISOL;
D O I
10.3389/fvets.2022.914659
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
An assay of circulating progesterone (P4) is commonly used to estimate progress through late gestation in the bitch. Point-of-care assays provide rapid results, a major advantage over laboratory-based assays. This study aims to compare P4 levels determined by the Catalyst (R) Progesterone point-of-care assay with those determined by chemiluminescent immunoassay (CLIA) and to identify the expected distribution of Catalyst P4 levels at time intervals 3 days prior to the onset of parturition in pregnant bitches. Twenty-eight pregnant bitches carrying two or more fetuses were admitted to a specialist veterinary reproduction hospital 53 days after the onset of cytological diestrus or, when that date was not known, 57 days after the last mating. Vaginal speculum examinations were performed every 6 h until the onset of cervical dilatation (TCD). Serum samples were collected twice daily (08h00 and 18h00) until TCD. For most samples, fresh serum was assayed for P4 immediately using the Catalyst assay (CatP4), then frozen until assayed by CLIA (IMMULITE 2000; ImmP4). However, for some samples, CatP4 was not analyzed prior to freezing. For these data points (n = 33), CatP4 for fresh serum was estimated from CatP4 assayed on frozen-thawed serum, based on a comparison between CatP4 on fresh vs. frozen-thawed sera. In comparison to ImmP4, CatP4 levels up to and including 7 nmol/L appear to have a constant bias of -1.69 nmol/L (limits of agreement -4.91 to 1.52), while levels >7 nmol/L appear to have a proportional bias of -17.9% (limits of agreement -68.6% to 32.7%). Bootstrapped percentiles of CatP4 results spanned 0.4-9 nmol/L within 12 h of TCD, 0.9-11 nmol/L 12-24 h from TCD, and 2.2-13.5 nmol/L 24-36 h from TCD. A CatP4 >9 nmol/L indicates a bitch that is unlikely to reach TCD within 12 h. Bitches with CatP4s below 3.5 nmol/L are likely to reach TCD within 36 h and bitches with a CatP4 below 2.2 nmol/L are likely to reach TCD within 24 h. In conclusion, the Catalyst Progesterone assay provides rapid assessment of circulating P4 in the bitch, with clinical application in the monitoring of late term pregnant bitches.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Can a point-of-care proteomic assay increase the accuracy of cystoscopy?
    John D Kelly
    Marie Westwood
    David E Neal
    Nature Clinical Practice Urology, 2005, 2 : 320 - 321
  • [32] A rapid point-of-care assay accurately measures vitamin D
    K. Albrecht
    J. Lotz
    L. Frommer
    K. J. Lackner
    G. J. Kahaly
    Journal of Endocrinological Investigation, 2021, 44 : 2485 - 2492
  • [33] Evaluation of a new point-of-care assay for urinary ketamine detection
    Marchioro, Lucio
    Bologna, Laura
    Pavan, Isabella
    Artusi, Carlo
    Ivanova, Mariela
    Liverani, Anna
    Polo, Giulia
    Zaninotto, Martina
    Plebani, Mario
    BIOCHIMICA CLINICA, 2011, 35 (05) : 363 - 367
  • [34] Performance of a quantitative point-of-care microalbumin and creatinine assay.
    Sedor, FA
    Kaestner, S
    Morin, C
    Gantzer, ML
    CLINICAL CHEMISTRY, 1998, 44 : A66 - A67
  • [35] A Simple Point-of-Care Microfluidic Immunomagnetic Fluorescence Assay for Pathogens
    Zhang, Rui-Qiao
    Liu, Shu-Lin
    Zhao, Wei
    Zhang, Wan-Po
    Yu, Xu
    Li, Yong
    Li, An-Jun
    Pang, Dai-Wen
    Zhang, Zhi-Ling
    ANALYTICAL CHEMISTRY, 2013, 85 (05) : 2645 - 2651
  • [36] Single cell HaloChip assay on paper for point-of-care diagnosis
    Ma, Liyuan
    Qiao, Yong
    Jones, Ross
    Singh, Narendra
    Su, Ming
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2016, 408 (27) : 7753 - 7759
  • [37] Need for a Point-of-Care Assay for Monitoring Antiplatelet and Antithrombotic Therapies
    Rao, Gundu H. R.
    STROKE, 2009, 40 (06) : 2271 - 2272
  • [38] Detection of bladder cancer using a point-of-care proteomic assay
    Grossman, HB
    Messing, E
    Soloway, M
    Tomera, K
    Katz, G
    Berger, Y
    Shen, Y
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07): : 810 - 816
  • [39] Nurse Practitioner Use of Point-of-Care Ultrasound in Critical Care
    Brunhoeber, L. Alexandra
    King, Joan
    Davis, Sarah
    Witherspoon, Briana
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (05): : 383 - 388
  • [40] Use of point-of-care ultrasound by a critical care retrieval team
    Mazur, Stefan M.
    Pearce, Andrew
    Alfred, Sam
    Sharley, Peter
    EMERGENCY MEDICINE AUSTRALASIA, 2007, 19 (06) : 547 - 552